Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
FCF1P5 is classified as a human pseudogene—a nonfunctional DNA sequence that resembles the protein-coding FCF1 gene, which in its active form is involved in ribosomal small subunit biogenesis and rRNA processing[10][4][1]. As a pseudogene, FCF1P5 does not encode a functional protein and is not a therapeutic target, receptor, or enzyme. Pseudogenes like FCF1P5 are typically characterized by sequence homology to their parent gene, but have lost the capacity for normal protein translation due to disruptive mutations such as frameshifts or premature stop codons[4]. There is no evidence in the scientific literature of FCF1P5 having a direct biological, disease, or drug target role. Its identification is clear and precise, and the name matches approved gene nomenclature conventions[10].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on FCF1 small subunit processome component homolog pseudogene 5 (FCF1P5).